Dental and Medical Journal - Review, cilt.4, sa.1, ss.59-71, 2022 (Hakemli Dergi)
Hepatitis E virus (HEV) is the second most common cause of enterically transmitted hepatitis after
hepatitis A virus infection. Little is known about the anti-HEV seroprevalence in our country. The main risk
groups for HEV infection are pregnant women, infants, the elderly, immunocompromised individuals, patients
with underlying chronic liver disease, and workers in close contact with HEV-infected animals. Seroprevalence
studies conducted in risk groups can help answer the questions of whether the HEV vaccine is necessary for
our country and if necessary, which groups should be vaccinated. In this study, we aimed to evaluate the
seroprevalence of HEV according to geographical regions and risk groups throughout our country.